tweetindex
ES

DoctorTro ✓

@DoctorTro · We see patients NATIONWIDE · joined 31 Dec 2010

Physician | Father | CMO @GoTowardHealth | ❤️‍🩹I help companies ⬇️ healthcare costs |💪🏻I help patients lose weight, improve diabetes | https://t.co/9COUe2aacl

172 579Followers
469Following
81 705Posts total
275.5KViews on collected posts

Últimas publicaciones

Later this month, I’ll have the amazing opportunity to meet real-food champion Mike Tyson in Washington, DC… I’m proud to support real food. I’m proud to support ketogenic diets and metabolic health. And I’m honored to represent the low-carb community at an upcoming Summit in 4.4K views · 69 likes · 7 reposts · 5 replies Open on X →
I wonder how many years of planning it took to execute population wide Alpha-Gal 7.6K views · 141 likes · 5 reposts · 6 replies Open on X →
Eat animal fats and animal proteins 5.6K views · 351 likes · 27 reposts · 7 replies Open on X →
Great discussion about cardiovascular health and proper patient selection for interventions. 5.3K views · 26 likes · 1 reposts · 1 replies Open on X →
@DoctorTro The reduction of LDL is not indicated, and neither is the use of statins. Period. 1.1K views · 17 likes · 0 reposts · 1 replies Open on X →
11/ Read the peer-reviewed study: https://t.co/Vipdyqvl5b Press release: https://t.co/Qf0vohYMVs Thank you to the patients who made this research possible ... and to our collaborators at @gotowardhealth, Wake Forest University School of Medicine, and INCMNSZ. https://t.co/RLurF 7.9K views · 19 likes · 1 reposts · 4 replies Open on X →
10/ Before employers and patients are directed toward the most expensive option, we should determine whether an inexpensive generic could achieve substantial LDL-C lowering in the appropriate phenotype. Better biology. Better targeting. Potentially far lower cost. 3.5K views · 13 likes · 0 reposts · 1 replies Open on X →
9/ This does NOT prove ezetimibe is equivalent to PCSK9... It was a retrospective, hypothesis-generating case series of 14 patients... But a median 53% LDL-C reduction is large enough to demand prospective study. 3.2K views · 13 likes · 0 reposts · 1 replies Open on X →
7/ This is precision medicine: Don’t just ask, “How high is the LDL?” Ask, “Why is the LDL elevated in this patient?” Understanding the mechanism may help identify a treatment that is more targeted, accessible, and affordable. 3.8K views · 16 likes · 0 reposts · 1 replies Open on X →
6) Lipidologists unfamiliar with ketogenic diets previously said this is due to genetic defects in ABCG5/8 We specifically tested ASCVD in multi-gene panels and found to relation to FH genes or sitosterolemia genes. Furthermore cholesterol balance testing did not predict this 8.9K views · 10 likes · 0 reposts · 1 replies Open on X →
8/ The economic question is unavoidable. Generic ezetimibe can cost roughly $10/month. PCSK9-targeting therapies can cost employers and health plans hundreds of dollars every month... often around $700... before administration and other costs. 3.5K views · 10 likes · 0 reposts · 1 replies Open on X →
5/ Ezetimibe blocks intestinal cholesterol absorption through NPC1L1. Our paper proposes that chronically low insulin may alter cholesterol esterification, absorption, recycling, and transport through unknown and novel pathways. 4.4K views · 15 likes · 0 reposts · 1 replies Open on X →
4/ The magnitude matters. In broader clinical trials, ezetimibe monotherapy typically lowers LDL by 15%. The response in this cohort was 3 times what is generally expected... Why might these patients respond differently? 4.6K views · 15 likes · 0 reposts · 3 replies Open on X →
3/ Four classes of drugs have been shown to DECREASE plaque, decrease CV death and also lower cholesterol (PCKS9, statins, ezetimibe, bempedoic acid). Other drugs and supplements have been shown to reduce plaque outside of cholesterol too (EPA, colchicine, nattokinase and 7K views · 35 likes · 3 reposts · 3 replies Open on X →
2/ We studied 14 patients who developed substantial LDL-C elevations while following a ketogenic diet. After treatment with ezetimibe: • Median LDL-C fell >53% • Total cholesterol fell nearly 39% • Triglycerides improved • HDL-C remained stable https://t.co/EiciKELnV8 5.9K views · 13 likes · 1 reposts · 1 replies Open on X →
1/ NEW STUDY: https://t.co/Vipdyqvl5b If a ~$10 generic drug reduced LDL by 53% on a ketogenic diet why should we use statins or injection antibodies? Why are cardiologists pushing drugs costing ~$700/month? A thread 🧵 92.9K views · 130 likes · 22 reposts · 11 replies Open on X →
🚨NEW PAPER🚨 https://t.co/L8LRquSKXZ @BioMedCentral: Lipids in Health and Disease. Ezetimibe ⬇️ LDL-C by a median of 53% in patients with keto-induced hypercholesterolemia. That is ~3x! what you would expect in conventional hypercholesterolemia (~18%). 🧵👇🏼 https://t.co/MkLEbg 105.9K views · 113 likes · 33 reposts · 16 replies Open on X →

Frente a cuentas del mismo tamaño

17 publicaciones de los últimos 90 días, junto al rango de 100K–1M seguidores. llega a mucha gente, pero pocos de esos espectadores reaccionan.

Visualizaciones medianas5 308esta cuenta5 983mediana de 100K–1M
Alcance, %3.08%esta cuenta1.49%mediana de 100K–1M
Interacción, %0.40%esta cuenta0.93%mediana de 100K–1M
MétricaEsta cuentaMediana de 100K–1MProporción
Visualizaciones medianas por publicación5 3085 9830.89×
Alcance (visualizaciones ÷ seguidores)3.08%1.49%2.06×
Tasa de interacción0.40%0.93%0.43×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

7K25 Aug
4.6K
4.4K
3.5K
8.9K
3.8K
3.2K
3.5K
7.9K
1.1K26 Aug
5.3K2 Sep
5.6K
7.6K3 Sep
4.4K

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.58%25 Aug
0.39%
0.36%
0.32%
0.13%
0.45%
0.44%
0.40%
0.32%
1.68%26 Aug
0.53%2 Sep
6.86%
1.99%3 Sep
1.83%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes64.6%1 006 in total
Reposts6.4%100 in total
Replies4.1%64 in total
Quotes1.2%19 in total
Bookmarks23.6%368 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Cuentas similares